Biological mechanisms in breast cancer invasiveness: Relevance to preventive interventions

European Journal of Cancer Prevention

Volumn 9, Issue 2, 2000, Pages 73-79

  Stoll, B A ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Cell adhesion molecules; Ductal carcinoma in situ; Hyperinsulinaemia; Insulin like growth factor 1; Invasiveness; Metalloproteinases; Protein kinase C; Urokinase plasminogen activator

Indexed keywords

CELL ADHESION MOLECULE; METALLOPROTEINASE; PROTEIN KINASE C; SOMATOMEDIN;

BREAST CANCER; CANCER INVASION; CANCER PREVENTION; CANCER RISK; ESTRADIOL BLOOD LEVEL; FEMALE; HEREDITY; HUMAN; HYPERINSULINEMIA; LIFESTYLE; PRIORITY JOURNAL; REVIEW;

ANIMALS; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CELL ADHESION MOLECULES; DISEASE PROGRESSION; ENVIRONMENT; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MATRIX METALLOPROTEINASES; NEOPLASM INVASIVENESS; POSTMENOPAUSE; PROTEIN KINASE C; RECEPTORS, ESTROGEN; URINARY PLASMINOGEN ACTIVATOR;

EID: 0034113166     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-200004000-00002     Document Type: Review

References (60)

1. Ahmad A, Hanby A, Dublin E, et al. (1998). Stromelysin 3; an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression. Am J Pathol 152: 721-8.
2. Alford D, Pitha-Rowe P, Taylor-Papadimitriou J (1998). Adhesion molecules in breast cancer; role of alpha 2 beta 1 integrin. Biochem Soc Symp 63: 245-59.
3. Barsky SH, Zhi-Ming Shao MD, Bose S (1999). Should DCIS be renamed carcinoma of the ductal system? Breast J 5: 70-2.
4. Bassett P, Bellocq JP, Wolf C, et al. (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348: 699-704.
5. Baxter RC (1994). Insulin like growth factor binding proteins in the human circulation. Hormone Res 42: 140-4.
6. Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS (1998). IGF1 in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 9: 570-3.
7. Bort DE (1995). Dietary modulation of epidermal protein kinase C; mediation by diacylglycerol. J Nutrition 125 (suppl 6): 1673-6.
8. Brobe GC, Obeid LM, Hannun YA (1994). Regulation of PKC and role in cancer biology. Cancer Metast Ret 13: 411-31.
9. Bruning PF, Bonfrer JMG, van Noord PAH, et al. (1992). Insulin resistance and breast cancer risk. Int J Cancer 52: 511-16.
10. Buell P, Dunn JE (1965). Cancer mortality among Japanese Issei and Nissei of California. Cancer 18: 656-67.
11. Carey I, Williams CL, Ways DK, Noti JD (1999). Overexpression of PKC alpha in MCF7 breast cancer cells results in differential regulation of expression of alpha versus beta 3 and alpha versus beta 5 integrins. Int J Oncol 15: 127-36.
12. Chan JM, Stampfer MJ, Giovannucci E, et al. (1998). Plasma IGF1 and prostate cancer risk; a prospective study. Science 279: 563-6.
13. Chapkin RS, Jiang YH, Davidson LA, Lupton JR (1997). Modulation of intracellular second messengers by dietary fat during colonic tumour development. Adv Exp Med Biol 422: 85-96.
14. Costantini V, Sidoni A, Deveglia R, et al. (1996). Combined overexpression of urokinase, urokinase receptor and PAI1 is associated with breast cancer progression. Cancer 77: 1079-88.
15. Del Giudice ME, Fantus IG, Ezzat S, et al. (1998). Insulin and related factors in premenopausal breast cancer risk. Breast Cancer Res Treat 47: 111-20.
16. Doll R, Payne P, Waterhouse J (1966). Cancer Incidence in Five Continents. A Technical Report. UICC, Springer Verlag, Berlin.
17. Ebeling P, Koistinen H, Seppala M, Koivisto VA (1998). Insulin in the regulation of IGFBP3 in healthy men and patients with type 1 diabetes mellitus. Diabetes Nutr Metab 11: 273-8.
18. Ellis MJC, Hayes DF (1997). Improving hormonal therapy for breast cancer. Breast J 3 (suppl): 57-68.
19. Gamayunova VB, Bobrov YF, Tsyrlina EV, et al. (1997). Comparative study of blood insulin levels in breast and endometrial cancer. Neoplasma 44: 123-6.
20. Giuffrida D, Lupo L, La Porta GA, et al. (1992). Relation between steroid receptor status and body weight in breast cancer patients. Eur J Cancer 28: 112-15.
21. Gonzalez MA, Pinder SE, Wencyk PM, et al. (1999). Immunohistochemical examination of the expression of E-cadherin, catenins and integrins in invasive breast cancer. J Pathol 187: 523-9.
22. Griffin ME, Marcucci MJ, Cline GW, et al. (1999). Free fatty acid-induced insulin resistance is associated with activation of PKC theta and alterations in the insulin signalling cascade. Diabetes 48: 1270-4.
23. Hahnel R, Geschwendt M (1995). The interaction between PKC and estrogens. Int J Oncol 7: 11-16.
24. Hankinson SE, Willett WC, Colditz GA, et al. (1998). Circulating concentrations of IGF1 and risk of breast cancer. Lancet 351: 1393-6.
25. Hilakivi-Clarke L, Stoica A, Raygada M, Martin MB (1998). Consumption of high-fat diet alters ER content, PKC activity and mammary gland morphology in virgin and pregnant mice and female offspring. Cancer Res 58: 654-60.
26. Holmes MD, Hunter DI, Colditz GA, et al. (1999). Association of dietary intake of fat and fatty acids with risk of breast cancer. JAMA 281: 914-20.
27. Jain M, Miller AB (1997). Tumor characteristics and survival of breast cancer patients in relation to premorbid diet and body size. Breast Cancer Res Treat 42: 43-55.
28. Jankun J, Merrick HW, Goldblatt PJ (1993). Expression and localization of elements of the plasminogen activation system in benign breast and breast cancers. J Cell Biochem 53: 135-44.
29. Johnson MD, Torri JA, Lippman ME, Dickson RB (1999). Regulation of motility and protease expression in PKC-mediated induction of MCF7 breast cancer cell invasiveness. Exp Cell Res 247: 105-13.
30. Jones JL (1998). Cadherin controls MMP9 expression in breast cancer cells [Abstract]. J Pathol 186 (suppl): A23.
31. Kennedy S, Duffy MJ, Duggan C, et al. (1998). Semi-quantitation of uPA and its receptor in breast carcinomas by immunocytochemistry. Br J Cancer 77: 1638-41.
32. Kushi LH, Potter JD, Bostick RM, et al. (1995). Dietary fat and risk of breast cancer according to hormone receptor status. Cancer Epidemiol Biomarkers Prev 4: 11-19.
33. Lee CCR, Masuda C, Wanibuchi H, et al. (1997). Cyclin D overexpression in bladder carcinogenesis and its relationship to oncogenes, tumor suppressor genes and cell proliferation. Cancer Res 57: 4765-76.
34. Leygue E, Detzlaw H, Watson PH, Murphy LC (1998). Altered oestrogen receptor alpha and beta messenger RNA expression during human breast tumorigenesis. Cancer Res 58: 3197-201.
35. Ma J, Pollak MN, Giovannucci E, et al. (1999). Prospective study of colorectal cancer risk in men and plasma levels of IGF1 and IGFBP3. J Natl Cancer Inst 91: 620-5.
36. Muti P, Liu J, Trevisan A, Menotti A (1997). Insulin resistance as a risk factor for colon and breast cancer [abstract]. Am J Epidemiol 145 (suppl 11): 25.
37. O'Brian CA, Vogel VG, Singletary SE, Ward NE (1989). Elevated PKC expression in human breast cancer biopsies relative to normal breast tissue. Cancer Res 49: 3215-17.
38. Perks CM, Gill ZP, Newcomb PV, Holly JMP (1999). Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of IGF1 in human breast cancer cell lines. Br J Cancer 79: 701-6.
39. Peters G, Fantl V, Smith R, et al. (1995). Chromosome llq13 markers and D-type cyclins in breast cancer. Breast Cancer Res Treat 33: 125-35.
40. Platet N, Prevostel C, Derocq D, et al. (1998). Breast cancer cell invasiveness; correlation with PKC activity and differential regulation by phorbol ester in ER positive and negative cells. Int J Cancer 75: 750-6.
41. Politis I (1996). Plasminogen activator system; implications for mammary cell growth and involution. J Dairy Sci 79: 1097-107.
42. Preziosi P, Barrett-Connor E, Papoz L, et al. (1993). Interrelation between plasma SHBG and insulin in healthy adult women. J Clin Endocrinol Metab 76: 283-7.
43. Proietto J, Filippis A, Nakhla C, Clark S (1999). Nutrient-induced insulin resistance. Mol Cell Endocrinol 151: 143-9.
44. Pujol P, Hilsenbeck SG, Chamness GC, Elledge RM (1994). Rising levels of estrogen receptor in breast cancer over 2 decades. Cancer 74: 1601-6.
45. Reaven GM (1988). Role of insulin resistance in human disease; Banting lecture. Diabetes 37: 1595-607.
46. Reddy BS, Simi B, Patel N, et al. (1996). Effect of amount and types of dietary fat on colonic mucosal DAG and PKC activities during stages of colon tumor promotion. Cancer Res 56: 2314-20.
47. Rha SY, Kim JH, Roh JH, et al. (1997). Sequential production and activation of MMP9 with breast cancer progression. Breast Cancer Res Treat 43: 175-81.
48. Rouyer N, Wolf C, Chenard MP, et al. (1994). Stromelysin-3 gene expression in human cancer; an overview. Invasion Metast 14: 269-75.
49. Schmitz-Pfeiffer C, Browne CL, Oakes ND, et al. (1997). Alterations in the expression and cellular localization of PKC isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high fat-fed rat. Diabetes 46: 169-78.
50. Shoker BS, Jarvis C, Sibson DR, et al. (1999). Oestrogen receptor expression in the normal and precancerous breast. J Pathol 188: 237-44.
51. Sternlicht MD, Kedeshian P, Shao ZM, et al. (1997). The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res 3: 1949-58.
52. Stoll BA (1996). Diet and exercise regimens to improve breast carcinoma prognosis. Cancer 78: 2465-70.
53. Tekden N, Kahraman H, Yucel I, et al. (1996). Insulin and C peptide response to oral glucose in patients with breast cancer [abstract]. Ann Oncol 7 (suppl 5): 24.
54. Toi M, Ishigaki S, Tominaga T (1998). Metalloproteinases and tissue inhibitors of metalloproteinases. Breast Cancer Res Treat 52: 113-24.
55. Van Dienst PJ (1999). Ductal carcinoma in situ in breast carcinogenesis. J Pathol 187: 383-4.
56. Vos CBJ, ter Haar NT, Peterse JL, et al. (1999). Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast. J Pathol 187: 279-84.
57. Wazer DE, Gage J, Homer M, et al. (1996). Age-related differences in patients with non palpable breast carcinomas. Cancer 78: 1432-7.
58. Welsch CW (1987). Enhancement of mammary tumorigenesis by dietary fat; review of potential mechanisms. Am J Clin Nutr 45: 192-202.
59. Yao KQ, Laske CM, Bird RP (1998). Modulating role of dietary fat, energy restriction and the effect of age on the expression of proliferating cell nuclear antigen and PKC activity in prostate glands of rats. J Nutr Biochem 9: 236-41.
60. Zhuang Z, Merino MJ, Chuaqui R, et al. (1995). Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer. Cancer Res 55: 467-71.